Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (14)
- Pharmaceutical Preparations (12)
- Pharmacy and Pharmaceutical Sciences (11)
- Diseases (10)
- Organic Chemicals (9)
-
- Other Pharmacy and Pharmaceutical Sciences (8)
- Cell and Developmental Biology (7)
- Amino Acids, Peptides, and Proteins (5)
- Cell Biology (5)
- Medical Sciences (5)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (4)
- Biological Factors (4)
- Cancer Biology (4)
- Mental and Social Health (4)
- Physical Sciences and Mathematics (4)
- Chemistry (3)
- Medical Biochemistry (3)
- Medicinal and Pharmaceutical Chemistry (3)
- Natural Products Chemistry and Pharmacognosy (3)
- Pharmacology, Toxicology and Environmental Health (3)
- Social and Behavioral Sciences (3)
- Substance Abuse and Addiction (3)
- Therapeutics (3)
- Animal Experimentation and Research (2)
- Biology (2)
- Biomaterials (2)
- Biomedical Engineering and Bioengineering (2)
- Institution
-
- Chapman University (10)
- City University of New York (CUNY) (3)
- University of New Mexico (3)
- Purdue University (2)
- Virginia Commonwealth University (2)
-
- Bellarmine University (1)
- Boise State University (1)
- Claremont Colleges (1)
- Illinois Math and Science Academy (1)
- Lesley University (1)
- Liberty University (1)
- Longwood University (1)
- Louisiana State University (1)
- Murray State University (1)
- Southern Methodist University (1)
- The University of Akron (1)
- Keyword
-
- Cerebral microbleeds (2)
- Chemistry (2)
- Chemotherapy (2)
- Histidine (2)
- Immunity (2)
-
- Phosphopeptides (2)
- 3D QSAR (1)
- 5-HT2B receptors (1)
- Aging (1)
- Altered States of Consciousness (1)
- Alzheimer’s (1)
- Animal models (1)
- Antibiotic (1)
- Antibiotic Resistance (1)
- Antibiotics (1)
- Anticancer drugs (1)
- Anxiety (1)
- Aryl Hydrocarbon receptor (1)
- Awareness (1)
- Aziridinomitosenes (1)
- Azomethine ylide (1)
- BET proteins (1)
- Biochemistry (1)
- Biofilm (1)
- Biology (1)
- Brain endothelial cells (1)
- Breast cancer (1)
- Broad-spectrum (1)
- Bromodomain inhibitors (1)
- Cannabis (1)
- Publication
-
- Pharmacy Faculty Articles and Research (8)
- Biology, Chemistry, and Environmental Sciences Faculty Articles and Research (2)
- Shared Knowledge Conference (2)
- The Summer Undergraduate Research Fellowship (SURF) Symposium (2)
- Theses and Dissertations (2)
-
- Boise State University Theses and Dissertations (1)
- CMC Senior Theses (1)
- Capstones (1)
- Chemistry Theses and Dissertations (1)
- Dissertations, Theses, and Capstone Projects (1)
- Expressive Therapies Capstone Theses (1)
- LSU Master's Theses (1)
- Pharmaceutical Sciences ETDs (1)
- Posters-at-the-Capitol (1)
- Senior Honors Theses (1)
- Spring Presentation of Undergraduate Research (1)
- Student Theses (1)
- The International Student Science Fair 2018 (1)
- Undergraduate Theses (1)
- Williams Honors College, Honors Research Projects (1)
- Publication Type
- File Type
Articles 31 - 31 of 31
Full-Text Articles in Other Chemicals and Drugs
Bromodomain And Extraterminal Domain (Bet) Inhibitor Rvx-208 Ameliorates Periodontal Bone Loss, Nicholas J. Clayton
Bromodomain And Extraterminal Domain (Bet) Inhibitor Rvx-208 Ameliorates Periodontal Bone Loss, Nicholas J. Clayton
Theses and Dissertations
Periodontal disease affects 47% of Americans over 30 and is a growing global concern. Current treatments for periodontal disease focus on the mechanical elimination of periodontal biofilms. Very few treatments are available that target the rampant, unregulated host immune response that is ultimately responsible for tissue degradation. BET proteins have been shown to play critical roles in inflammatory gene regulation and are therefore potentially ideal therapeutic targets for treating periodontal disease. RVX-208 is a selective BET-inhibitor with a high affinity for Bromodomain 2 (BD2) as compared to BD1 in BET proteins. Our previous studies have shown that RVX-208 inhibits inflammatory …